Amgen accused of giving kickbacks to boost Aranesp sales
Fifteen states sued Amgen for allegedly bribing health care providers to bill insurers for anemia drug Aranesp, leading to overpayment from Medicaid and private insurance companies. The claims are without merit, Amgen said, and it is prepared "to examine these matters with the states before the court."
Los Angeles Times | 10/31
This story published in FDLI SmartBrief on 11/02/2009
More from SmartBrief:
2 doctors' groups oppose independent panel for Medicare payments
Wednesday, July 29, 2009
Baucus to unveil health bill without government-run option
Tuesday, September 15, 2009
Appeals court revives Medicare-fraud suit against J&J unit
Friday, August 14, 2009
Get stories like these delivered daily for FREE:
|
FDLI SmartBrief
Designed specifically for professionals involved in the food and drug industry, FDLI SmartBrief is a FREE daily e-mail newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition. Learn more |
|